Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug
Status:
Completed
Trial end date:
2007-08-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define the absorption, breakdown and excretion of a single
dose of radiolabelled SB-649868 and its breakdown products by measuring their concentration
in blood, urine and faeces over a 7-10 day period. "Radiolabelled" means that the test drug
has a radioactive component to help us track the drug. The safety and tolerability of the
test drug will also be assessed.